Home Hot keywords

Search Modes

全部

搜索结果

作者:DJ Del Gaizo2019 — Liposomal Bupivacaine: Market Penetration Versus Scientific Evidence: Only the Facts. Del Gaizo, Daniel J. MD.
2021年6月30日 — ... Exparel (bupivacaine liposome injectable suspension) has generated impressive sales after its ...
2020年9月17日 — a marketing authorisation to Exparel on ... Exparel liposomal prolonged release dispersion for ...
2020年12月10日 — Exparel liposomal. bupivacaine. Table of contents. Overview; Authorisation details; Product information ...
2020年11月18日 — EXPAREL (bupivacaine liposome injectable suspension) is indicated for single-dose infiltration in adults ...
2021年1月7日 — Sales of bupivacaine liposome injectable suspension to a third-party licensee for use in veterinary ...

用户还搜索了

2021年3月22日 — ... Drug Application for EXPAREL® (bupivacaine liposome injectable suspension) in Pediatric Patients.
2021年8月2日 — 11,033,495 related to EXPAREL. The patent, “Manufacturing of Bupivacaine Multivesicular Liposomes,” ...
See full prescribing information for. EXPAREL. EXPAREL (bupivacaine liposome injectable suspension). Initial U.S. ...
缺少字词: market ‎| 必须包含: market
Exparel is a long-acting, sustained-release formulation of bupivacaine HCL, a local anesthetic widely used for ...

Page Navigation

google search trends